Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 7110 (miR-7110, hsa-miR-7110) is a small, single-stranded non-coding RNA molecule belonging to the microRNA class, which regulate gene expression post-transcriptionally by binding to complementary sequences on target mRNAs and directing their silencing or degradation. Elevated levels of miR-7110 have been observed in oral squamous cell carcinoma relative to normal tissue, implicating this molecule as a possible diagnostic/prognostic biomarker and a therapeutic target in this cancer. The detailed gene targets and broader functional roles of miR-7110 remain to be elucidated, and further research is needed to characterize its mechanisms and disease associations.
Not established for miR-7110 specifically; generally, microRNAs act by base-pairing with target mRNA to repress translation or accelerate degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 7110 (miR-7110).